What is On The Menu?
Established in 2004, On The Menu operates as a specialized consultancy firm providing critical infrastructure for the food industry. The company bridges the gap between complex FDA regulatory requirements and practical business application, offering services that include menu nutrition labeling, allergen and gluten tracking, and comprehensive food labeling support. By providing scientifically-backed analysis, the firm serves as an essential partner for restaurants and food manufacturers aiming to navigate the increasingly stringent landscape of food safety and consumer health information. Their market position is defined by a commitment to precision and personalized service, which has allowed them to maintain a consistent growth trajectory since their inception.
How much funding has On The Menu raised?
On The Menu has raised a total of $19K across 1 funding round:
Debt
$19K
Debt (2021): $19K with participation from PPP
Key Investors in On The Menu
PPP
Public-Private Partnership
What's next for On The Menu?
With the recent influx of financing, On The Menu is poised to transition into a more aggressive growth phase. The company intends to utilize this capital to enhance its technological capabilities, potentially automating aspects of its nutrition analysis and allergen tracking platforms to serve a broader client base. As the food industry continues to face heightened scrutiny regarding ingredient transparency and health labeling, the firm's expertise becomes increasingly vital. Future strategic initiatives will likely focus on expanding their footprint in the manufacturing sector, where demand for rigorous, compliant labeling solutions is at an all-time high. This Series A/B growth stage marks a pivotal moment for the firm as it seeks to solidify its reputation as a leader in food industry regulatory consulting.
See full On The Menu company page
